To Evaluate The Role Of Individualized Homoeopathic Medicine In The Treatment Of Atopic Dermatitis A Randomized Control Trial

AIM: To evaluate the efficacy of individualized homoeopathic medicine in the treatment of atopic dermatitis.

OBJECTIVE:

1.To identify and evaluate common triggering factors responsible for atopic dermatitis in children.

2. To study the miasmatic predominance of atopic dermatitis and its homoeopathic approach.

3. To monitor changes in Scoring of atopic dermatitis (SCORAD) after giving homoeopathic medicine

INTRODUCTION:

Atopic dermatitis is an inflammatory non-communicable skin disorder. The casual symptoms include itching, typical morphology, and occurrence of rash, chronic relapsing pattern. Itching is the most commonly associated feature. It is usually preceded by rash that might be severe, generally during night that is followed by inflammatory red to brownish colored patches with small bumps. These patches may exudate fluid and crust is formed over them when scratched. They may occur wherever on the body, but they most commonly appear on the flexural surfaces of the joints like inner sides of elbows, knees, and ankles. The skin is dry, scaly with cracks on visual examination making it prone to environmental allergens. There are few factors that worsen the presentation of dermatitis. Environmental factors like staphylococcal skin infection, humidity, pollution, exposure to detergents and stress plays crucial role as a precipitating factor. The etiology for dermatitis is destruction of epidermal barrier destruction by immune system 12 disharmony as a result of gene environmental interaction. Stress is also a very crucial factor in depression.

STUDY PROCEDURE: This clinical study aims to evaluate the effectiveness of individualized homeopathic treatment for atopic dermatitis, beginning with a target sample size of 96 participants. Each patient undergoes a thorough case-taking process, including detailed history, general physical examination, and specific assessment for atopic dermatitis, with diagnosis confirmed using ICD-10 criteria. Eligible patients are then randomized into two equal groups of 48 using a shuffled deck of cards—assigning even numbers to the treatment group and odd numbers to the control group. Baseline severity of atopic dermatitis is assessed using the SCORAD scale before initiating individualized homeopathic treatment for the treatment group. Participants are followed up at intervals of 15 days, 1 month, 2 months, and 3 months, with flexibility based on clinical condition. At the end of all follow-ups, SCORAD scoring is repeated to evaluate clinical improvement in both groups. The collected data is analyzed using appropriate statistical tools to interpret changes in scores, comparing the treatment group with the placebo group. Finally, the study concludes with the formulation of results and discussion based on the observed outcomes.